Abstract
Treatment of [Cp*RuCl2 ]2 , 1, [(COD)IrCl]2 , 2 or [(p-cymene)RuCl2 ]2, 3 (Cp*=η5 -C5 Me5, COD= 1,5-cyclooctadiene and p-cymene=η6 -i PrC6 H4 Me) with heterocyclic borate ligands [Na[(H3 B)L], L1 and L2 (L1 : L=amt, L2 : L=mp; amt=2-amino-5-mercapto-1,3,4-thiadiazole, mp=2-mercaptopyridine) led to the formation of borate complexes having uncommon coordination. For example, complexes 1 and 2 on reaction with L1 and L2 afforded dihydridoborate species [LA M(μ-H)2 BHL] 4-6 (4: LA =Cp*, M=Ru, L=amt; 5: LA =Cp*, M=Ru, L=mp; 6: LA =COD, M=Ir, L=mp). On the other hand, treatment of 3 with L2 yielded cis- and trans-bis(dihydridoborate) species, [Ru{(μ-H)2 BH(mp)}2 ], cis-7 and trans-7. The isolation and structural characterization of fac- and mer-[Ru{(μ-H)2 BH(mp)}{(μ-H)BH(mp)2 }], 8 from the same reaction offered an insight into the behaviour of these dihydridoborate species in solution. Fascinatingly, despite having reduced natural charges on Ru centres both at cis-and trans-7, they underwent hydroboration reaction with alkynes that yielded both Markovnikov and anti-Markovnikov addition products, 10 a-d.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.